Gaucher
Epidemiology and
Etiology:
·
cluster of autosomal recessive
disorders
·
mutations in the GBA gene (1q21) encoding glucocerebrosidase
(glucosylceramidase)
·
enzyme that normally cleaves the glucose residue from ceramide
·
Glucocerebrosides are continually
formed from the catabolism of glycolipids derived
mainly from the cell membranes of senescent leukocytes and erythrocytes
·
As a result, glucocerebroside
accumulates principally in the phagocytic cells of
the body but in some forms also in the central nervous system
·
most common lysosomal storage disorder
·
type I (chronic non-neuronopathic)
·
reduced but detectable levels of glucocerebrosidase
activity
·
glucocerebrosides is limited to
the mononuclear phagocytes throughout the body without involving the brain
·
principally in Jews of European stock
·
type II (acute neuronopathic)
·
virtually no detectable glucocerebrosidase
activity
·
no predilection for jews
·
type III
·
intermediate form
·
Common sites:
·
type I
·
spleen
·
bone marrow
·
type II
·
hepatosplenomegaly
·
progressive CNS involvement begins in infancy
·
type III
·
progressive CNS involvement begins in teens or twenties
Gross features:
·
splenomegaly (type I)
·
uniformly pale or mottled
·
lymphadenopathy (mild to
moderate, generalized)
·
bone
·
pathologic fractures (type I)
Histologic
features:
·
Distended phagocytic cells (Gaucher cells) in spleen, liver, bone marrow, lymph nodes,
tonsils, thymus, Peyer’s patches
·
Crumpled tissue paper appearance of cytoplasm (not vacuolated)
Immunophenotype
& Special Stains:
Marker: |
Sensitivity: |
Specificity: |
PAS
(intense) |
|
|
Molecular features:
·
GBA gene (1q21) mutations
·
more than 150 allelic mutations
·
N370S, 84GG, IVS2+1G>A, and L444P account for 90% of the
mutant alleles in Ashkenazi Jewish individuals with type 1 GD and for 50%-60%
of mutant alleles in non-Jewish individuals with type 1 GD
Other features:
·
Diagnosis by measurement of glucocerebrosidase
activity in peripheral blood leukocytes or in extracts of cultured skin
fibroblasts
·
Chitotriosidase, an enzyme
synthesized by macrophages, is markedly elevated (reasonably specific)
·
EM:
·
Elongated, distended lysosomes
containing stored lipid in stacks of bilayers
·
Pancytopenia or
thrombocytopenia due to hypersplenism
·
Progressive CNS dysfunction (types II and III)
·
Convulsions
·
Progressive mental deterioration
·
Prognosis:
·
Type I
·
Longevity is shortened but not markedly
·
Type II
·
Death at an early age due to progressive CNS involvement
References:
·
Kumar V, Fausto N, Abbas
A. Robbins & Cotran Pathologic Basis of Disease,
Seventh Edition. 7th ed. Saunders; 2004:1552.